Advance in Nanorealgar Studies

Transcript

1 PROGRESS IN CHEMISTRY Vol. 21 No. 5 May, ( ; ),,, ;,, : O61316 ; R284 : A : X(2009) Advance in Nanorealgar Studies Ye Xiaochuan 1 Yang Xiangliang 1 Xu Huibi 2 3 (1. College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan , China ; 2. College of Chemistry and Chemical Technology, Huazhong University of Science and Technology, Wuhan , China) Abstract Mineral drug realgar has been extensively used in traditional Chinese medicine for a long time. Its therapeutic effects have attracted increasing attentions in recent years. However, the poor bioavailability owing to its poor water2solubility and potential toxicity hamper it from clinical applications. These problems may be improved when realgar is processed using nanotechnology. The pharmacokinetics of arsenic between nanorealgar and fraditionally prepared realgar is notably varied. Based on the studies of our group and other researchers, some aspects of nanorealgar are summarized in the paper, including preparation methods and characterization, pharmacokinetic behavior, mechanism of antitumour activity, active species and Chinese medicinal formulae of nanorealgar. Moreover, the further research trends of nanorealgar are also discussed. Key words nanorealgar ; bioavailability ; pharmacokinetics ; active ingredients ; antitumour effect ; Chinese medicinal formulae Contents 1 Preparation methods and characterization of nanorealgar 2 Pharmacokinetic of nanorealgar 3 Action mechanism of antitumour of nanorealgar 4 Active species of nanorealgar 5 Chinese medicinal formulae of nanorealgar 6 Prospect 6. 1 Hormesis effect of nanorealgar 6. 2 Pharmacokinetics of nanorealgar and its formulae, : ( ) 3 e2mail hust. edu. cn

2 5 935 (acute promyelocytic leukemia,apl) (chronic myelogenors leukemia,cml) [1 5 ], As 2 S 2 ( As 4 S 4 ), (As 2 O 3 ),,, 20nm,,,,, 62 [1 ], (As 2 S 2 ), As 2 O 3, As 2 S 2,, [6 11 ] 1,, [11 ] (1 100nm) [12 ], X (XRD) (SEM) ( TEM),,, ; XRD,, 20nm, ;,,, ( ),,, SEM TEM,, 200nm, [13 ] 500,,,, 280, :,, [14 ], 1,22,,,, 1,22, nm, [15 ],,, 2, [16 ], 50mg,,, [17 ]

3 936 21,,,, Wu [18 ],,, 48h, 5815 % 6916 %, 2419 % [19 ] Wistar 5, 10 ; gπg,,,,,, [10 ] [20 ],, : (ias ) (MMA ) (MMA ) (DMA ) (DMA ) ( TMA ) ( GSH) (MMA DMA),,, ( ), hormesis,, hormesis [21 ], [22 ],, 3, DNA, [6 ] ECV2304, ( < 100nm, 150nm, 200nm, 500nm) ECV2304, nm, % % 7151 % 5121 %,, 150nm [7 9 ] HL260,, DNA ladder, G 0 ΠG 1,,,, Bcl22 mrna HL260, 36h, CAT, ROS,,,, Wang [23 ], U937 DNA,caspase MAPK U937 [24 ] Siha HPV16E6 E7 Siha, HPV16E6 E7, [25 ]

4 [26,,, [29,30 ] As 2 O 3,, [12,33 ] [34 ], As 2 S 2, As 2 O 3 ; [35 ],, 2 ( LD 50, 650mgΠkg, As 2 O 3 LD mgΠkg), Lengke [31 ],, [14 ], K562 HL260 As 2 O 3,,, ;, ( H 3 AsO 3, As 2 O 3, ; ) H 3 AsO 3,, ;, H 3 AsO 3, As 2 O 3,,,,,,,, Hansen [32 ], As O As S As O,,,,, 5,, 4 193,,,,,

5 938 21,,, [37 ],,,, 612 ( ) (APL) NB4,, NB4 As 2 S 2, IC 50 As( ) As( ), 81683mg L - 1, IC mg L - 1, [38 ], IC mg L - 1 APL NB4, APL NB4,,, ;,,,,,, 6 [21 ],, [39,40 ], ( ), P450,,, [34 ],, 611 hormesis ( ), ( ),, ( ),,, [ 1 ] (Lu D P), (Qiu J Y), (Chen S S). (Chinese Journal of Laboratory Diagnosis), 1998, 6 : 319 [ 2 ] (Wang M C), ( Guo G L), (Liu S X). ( Shaanxi Medical Journal), 2002, 31 (2) : [ 3 ] ( Guan J P), ( Yuan W), ( Yang H). (Shaanxi Oncology Medicine), 2002, 10 (4) : [ 4 ] (Wang M C), (Liu S X), (Li X M). (Journal of Clinical Hematology), 2003, 16 ( 6) : [ 5 ] (Jia Y M), (Liu S X). ( Chinese Journal of Primary Medicine and Pharmacy), 2004, 11 (2) :

6 5 939 [ 6 ] Ying D, Hui B X, Kai X H, et al. Pharmacol. Res., 2001, 44 (6) : [ 7 ] Ye H Q, Gan L, Yang XL, et al. Biol. Trace. Elem. Res., 2005, 103 (2) : [ 8 ] Ye H Q, Yang X L, Gan L, et al. Conf. Proc. IEEE. Eng. Med. Biol. Soc., 2005, 7 : [ 9 ] ( Ye H Q). (Study on the Antitumor Mechanism of Realgar Nanoparticles). (Doctoral Dissertation of Huazhong University of Science and Technology), 2005 [10 ] (Xu L Y), (Zeng F D), ( Ye H Q). ( Chinese Journal of New Drugs), 2006, 15 ( 21) : [11 ] (Xie C S), ( Yang X L), ( Xu H B). ZL , 2003 [12 ] (Wang X B), (Xi R G), (Li ZL). (Pharmaceutical Journal of Chinese People s Liberation Army), 2002, 18 (3) : [13 ] (Zhan X Q ), ( Guo L W), ( Fu T M). (Journal of Nanjing University of Traditional Chinese Medicine), 2003, 19 (1) : [14 ] (Ning N), (Peng Z F), (Zhang TL). ( China Journal of Chinese Materia Medica), 2005, 30 (2) : [15 ] (Shen X C), (Liang H), ( Chen Y). ZL , 2008 [16 ] (Wang X B), ( Xi R G). ( Pharmaceutical Journal of Chinese People s Liberation Army), 2002, 18 (6) : [17 ] (Zhan X Q ), ( Zhao F M), ( Guo L W). ( Journal of Practical Traditional Chinese Medicine), 2006, 22 (7) : [18 ] Wu J Z, Ho P C. Eur. J. Pharm. Sci., 2006, 29 (1) : [19 ] (Cheng ZJ), (Zhao L), (Li Z). ( China Journal of Chinese Materia Medica ), 2000, (supplement) : 60 [20 ] Goering P L, Aposhian H V, Mass M J, et al. Toxicol Sci., 1999, 49 (1) : 5 14 [21 ] (Wang K). ( Progress in Chemistry), 1999, 2 : [22 ] (Shen P W). ( Inorganic Chemistry). : (Beijing : Chemical Industry Press), [23 ] Wang X B, Gao H Y, Hou B L, et al. Arch. Pharm. Res., 2007, 30 (5) : [24 ] (Liu R), (Pu D M), (Zhao L B). (China Journal of Chinese Materia Medica), 2008, 33 (1) : [25 ] (Luo L Y), (Zhang TL), (Wang K). (China Journal of Chinese Materia Medica), 2006, 31 (16) : [26 ] (Du G Y). (Modern Research and Reasonable Application of Toxic Traditional Chinese Medicine). : (Beijing : People s Medical Publishing House), [27 ] (Wang K). ( Trace Elements in Life Science). (The Second Edition). : (Beijing : China Metrology Publishing House), [28 ] (Ou YJ), (Shi Y), (Zhang X R). (Chinese Journal of Analytical Chemistry), 1999, 27 (10) : 1l [29 ] (Zhang W), ( Yu B Y), ( Kou J P). ( Chinese Journal of Natural Medicines), 2004, 3 (2) : [30 ] (Fan Q R), ( Kou J P), ( Yu B Y). (Chinese Journal of Natural Medicines), 2007, 5 (1) : [31 ] Lengke M F, Tempel R N. Geochim. Cosmochim., 2003, 67 : 859 [32 ] Hansen H R, Raab A, Jaspars M, et al. Chem. Res. Toxicol., 2004, 17 : [33 ] (Wang B Q), (Pang Z G), (Cao Z Q). (Journal of Instrumental Analysis), 1996, 15 (6) : 23 [34 ] (Tang Y S), (Wang N S). (Chinese Journal of Current Traditional and Western Medicine ), 2005, 3 (9) : 769 [35 ] (Wang X P), (Cao Z Q), (Lu X Y). (Studies of Trace Elements and Health), 2003, 20 (4) : [36 ] Wang L, Zhou G B, Chen Z, et al. Proc. Natl. Acad. Sci. USA, 2008, 105 (12) : [37 ] (Wang X B), ( Xi R G), ( Yao X M). ( Chinese Journal of New Drugs), 2007, 16 (22) : [38 ] (Liu Q), (Wang Z J), (Tang H X). ( Environmental Science), 1996, 17 (1) : [39 ] (Xu J H), (Wang H W), (Wang Q). (Chinese Journal of Pharmaceutical Analysis), 2007, 27 (3) : [40 ] (Tang Y S), (Wang N S). (Journal of Modern Food and Pharmaceuticals), 2007, 17 (2) : 30 34